E
Evodiabio
Offers disruptive yeast-based technology that enables consumers to enjoy the benefits of non-alcoholic beer without having to compromise on taste
About Evodiabio
EvodiaBio is a pioneering startup that is redefining the production of natural aromas. The company's mission is to create a sustainable future where consumers can enjoy great taste and smell without exhausting natural resources. The company operates in the market of aromatic innovation, which is a niche but rapidly growing sector.
EvodiaBio's primary business model revolves around the application of fermentation to produce natural and environmentally friendly aromas. This innovative approach is not only sustainable but also has the potential to revolutionize a wide range of industries, starting with the beer industry. The company's target clients are businesses in various sectors that require natural aromas for their products, including food and beverage, cosmetics, and personal care industries.
The company generates revenue by selling these natural aromas to businesses. As the demand for sustainable and natural products continues to grow, EvodiaBio is well-positioned to capitalize on this trend and achieve significant growth.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Copenhagen, Denmark
- Employees
- 30
- Open positions
- 1
- Dealroom signal
- 64.3/100
- Sub-industry
- Innovative Food
- Sector
- Food, Biotechnology, Synthetic Biology, Spinout, Alternative Protein, Sustainable Development Goals, Fermentation, Climate Tech, Functional Beverages, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Dec 2025 | $6.6M | $38M | Flemming Besenbacher · Jarne Elleholm · Newtree Impact · Camilla Fenneberg | ↗ |
| EARLY VC✓Equity / VC | Jun 2024 | $7.7M | $31M | The March Group · Export and Investment Fund of Denmark | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Evodiabio is 240 monthly website visits, down 63.6% over the last three months. Evodiabio's team grew 7.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A15 investors entered at this stage
BioInnovation Institute
Symrise
Nordic FoodTech VC
The March Group
Export and Investment Fund of Denmark
RA Capital Management- FBFlemming Besenbacher
- JEJarne Elleholm
Newtree Impact- CFCamilla Fenneberg
Ananke Ventures
PINC- FFFrancis Family Fund
Sotirios Kampranis
Anne Cabotin
Other known investors2 additional known investors
University of Copenhagen
Thia Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Evodiabio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Evodiabio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.